Skip to content

Modified Endotracheal Balloon Dilator to Improve Patient Oxygenation and Allow Ventilation During Airway Procedures

Modified Endotracheal Balloon Dilator to Improve Patient Oxygenation and Allow Ventilation During Airway Procedures

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02796326
Enrollment
20
Registered
2016-06-10
Start date
2016-10-31
Completion date
2017-09-30
Last updated
2017-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tracheal Stenosis

Keywords

tracheal stenosis, tracheal dilatation, ventilation

Brief summary

The purpose of the study is to prospectively assess the use of a modified tracheal balloon dilator that allows gas flow (oxygenation and ventilation) through the device while inflated during dilatation.

Detailed description

The primary aim is to determine the incidence of, and time to, arterial desaturation (defined as peripheral plethysmography below 90%). Secondary aims include quantitative and qualitative (waveform) end-tidal capnography levels throughout the procedure, quantitative assessment of dilatation, and incidence of adverse events.

Interventions

DEVICEimproved tracheal balloon dilatation

Treatment for laryngotracheal stenosis using a modified tracheal dilatation balloon

Sponsors

University of Cape Town
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \>18 years * Symptoms of tracheal or laryngeal stenosis or airway narrowing * Endoscopic evidence of subglottic or tracheal stenosis * Able to provide informed consent

Exclusion criteria

* Refractory stenosis not amenable to balloon dilatation * Contraindication to balloon dilatation * Lack of informed consent

Design outcomes

Primary

MeasureTime frameDescription
Incidence of peripheral arterial desaturationDuring procedure (up to 60 minutes duration)Incidence of desaturation below 90% as measured by peripheral pulse oximeter
Time to desaturationDuring procedure (up to 60 minutes duration)Time to desaturation below 90% as measured by peripheral pulse oximeter

Secondary

MeasureTime frameDescription
Efficacy of tracheal dilatation by comparison of pre- and post-dilatation Myer-Cotton gradingDuring procedure (up to 60 minutes duration)Describes the stenosis based on the percent relative reduction in cross-sectional area of the subglottis. Four grades of stenosis: grade I lesions have less than 50% obstruction, grade II lesions have 51% to 70% obstruction, grade III lesions have 71% to 99% obstruction, grade IV lesions have no detectable lumen or complete stenosis.
Incidence of major adverse eventsDuring and within 24 hours of procedure

Countries

South Africa

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026